Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

The Association of Sarcopenia with Chronic Kidney Disease (CKD) and Decline in Kidney Function.

FY 2022-23

Summary
Chronic kidney disease (CKD) is a health problem with an increasing incidence and prevalence worldwide. Muscle loss occurs naturally in humans through aging, known as primary sarcopenia. However, patients with CKD are prone to muscle catabolism. This causes secondary sarcopenia which is accelerated muscle loss. Sarcopenia is diagnosed via appendicular dual energy X-ray absorptiometry (DEXA), however, the scans required for diagnosis are expensive and time consuming. Recently, an algorithm for determining appendicular muscle mass from partial hip and spine DEXA scans has been developed. We propose to apply this algorithm to determine muscle mass in patients who have a hip and spine DEXA scan and classify those patients by CKD status. We aim to determine the association between CKD and muscle mass both at baseline as well as change over time. We will also determine the association between muscle mass and hospitalizations and all-cause mortality by CKD status. We will conduct a retrospective cohort study that links data from various databases held at the Manitoba Centre for Health Policy. The cohort will include adults in Manitoba who have a DEXA scan and a serum creatinine test (used for CKD staging by estimated glomerular filtration rate (eGFR)). A linear regression of eGFR or CKD stage predicting baseline muscle mass will be calculated. A mixed linear regression model will be used to assess the effects of eGFR or CKD stage on change in muscle mass over time. We will execute Cox proportional hazards regression models for baseline muscle mass predicting time to hospitalizations and death with eGFR and CKD stage as interaction terms. All regression models will adjust for confounders such as age, sex, diabetes, hypertension, and cardiovascular disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486546
Name
Alexiuk Mackenzie R
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Association of Sarcopenia with Chronic Kidney Disease (CKD) and Decline in Kidney Function.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Clinical Outcomes; Chronic Kidney Disease (Ckd); Epidemiology; Older Adults; Sarcopenia
Abstract
Chronic kidney disease (CKD) is a health problem with an increasing incidence and prevalence worldwide. Muscle loss occurs naturally in humans through aging, known as primary sarcopenia. However, patients with CKD are prone to muscle catabolism. This causes secondary sarcopenia which is accelerated muscle loss. Sarcopenia is diagnosed via appendicular dual energy X-ray absorptiometry (DEXA), however, the scans required for diagnosis are expensive and time consuming. Recently, an algorithm for determining appendicular muscle mass from partial hip and spine DEXA scans has been developed. We propose to apply this algorithm to determine muscle mass in patients who have a hip and spine DEXA scan and classify those patients by CKD status. We aim to determine the association between CKD and muscle mass both at baseline as well as change over time. We will also determine the association between muscle mass and hospitalizations and all-cause mortality by CKD status. We will conduct a retrospective cohort study that links data from various databases held at the Manitoba Centre for Health Policy. The cohort will include adults in Manitoba who have a DEXA scan and a serum creatinine test (used for CKD staging by estimated glomerular filtration rate (eGFR)). A linear regression of eGFR or CKD stage predicting baseline muscle mass will be calculated. A mixed linear regression model will be used to assess the effects of eGFR or CKD stage on change in muscle mass over time. We will execute Cox proportional hazards regression models for baseline muscle mass predicting time to hospitalizations and death with eGFR and CKD stage as interaction terms. All regression models will adjust for confounders such as age, sex, diabetes, hypertension, and cardiovascular disease.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alexiuk, Mackenzie R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Manitoba - $17,500 Grant (2022-23) | Canada Spends